Ann: AVITA Medical to Announce First Quarter 2023 Results, page-24

“The National Institute for Health and Care Excellence (NICE) in the UK is responsible for providing guidance and recommendations on the use of healthcare treatments and technologies. While NICE has generally been well-received, there have been some criticisms and concerns raised about its medical review process. Some of the negative criticisms include:

Lack of transparency: Some critics have argued that NICE's review process is not transparent enough, and that it can be difficult for patients and healthcare professionals to understand how decisions are made.

Cost-effectiveness: NICE uses a cost-effectiveness threshold called the Quality-Adjusted Life Year (QALY) to evaluate the value of treatments. Some have argued that this approach is too focused on cost and may not take into account the full range of benefits that a treatment can provide.

Delays: NICE's review process can sometimes be slow, which can be frustrating for patients and healthcare professionals who are waiting for guidance on a particular treatment.

Conflict of interest: Some have raised concerns about the potential for conflicts of interest among the experts who serve on NICE committees, and have argued that this could influence the recommendations that are made.

Access to treatments: Some patients and advocacy groups have criticized NICE for not recommending certain treatments or technologies that they believe could be beneficial, and for creating barriers to access.

It's worth noting that while there have been criticisms of NICE, the organization has also received praise for its evidence-based approach to evaluating healthcare treatments and technologies, and for its efforts to ensure that patients have access to effective and affordable care.” —ChatGPT